Keep Me Logged In
John Maraganore, Alnylam Pharmaceuticals president & CEO, and CNBC's Meg Tirrell, discuss the company's research into RNAi therapy, a process which turns off the gene's ability to "do something bad." Also Maraganore weighs in on drug pricing.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by